Search research articles
Contact Us
Filters
Showing results (31-40 of 482) with videos related to
Page
of 49
Sort By:
Leukemia Research
|
February 4, 2012
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
Uwe Platzbecker, Lorenz C Hofbauer, Gerhard Ehninger, et al.
Frontiers in Oncology
|
April 18, 2022
Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series
Anna Stein, Anne Sophie Kubasch, Claudia Haferlach, et al.
European Journal of Haematology
|
August 7, 2023
CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?
Luise Fischer, Nora Grieb, Uwe Platzbecker, et al.
British Journal of Haematology
|
August 30, 2002
CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back
Martin Bornhäuser, Uwe Platzbecker, Catrin Theuser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2007
The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors
Caroline Pabst, Holger Schirutschke, Gerhard Ehninger, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy
Tilman D Rachner, Uwe Platzbecker, Dieter Felsenberg, et al.
Leukemia
|
May 28, 2021
Current challenges and unmet medical needs in myelodysplastic syndromes
Uwe Platzbecker, Anne Sophie Kubasch, Collin Homer-Bouthiette, et al.
Frontiers in Oncology
|
March 7, 2022
Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML
Julia-Annabell Georgi, Sebastian Stasik, Martin Bornhäuser, et al.
Leukemia & Lymphoma
|
March 12, 2025
Allogeneic stem cell transplantation for MDS-clinical issues, choosing preparative regimens and outcome
Lara Bischof, Jule Ussmann, Uwe Platzbecker, et al.
Clinical Hematology International
|
November 7, 2023
Are We Ready For "Triplet" Therapy in Higher-Risk MDS?
Andrew M Brunner, Uwe Platzbecker, Amy E DeZern, et al.
Page
of 49
Search research articles
Search
Showing results (31-40 of 482) with videos related to
Sort By:
Page
of 49
Leukemia Research
|
February 4, 2012
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
Uwe Platzbecker, Lorenz C Hofbauer, Gerhard Ehninger, et al.
Frontiers in Oncology
|
April 18, 2022
Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series
Anna Stein, Anne Sophie Kubasch, Claudia Haferlach, et al.
European Journal of Haematology
|
August 7, 2023
CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?
Luise Fischer, Nora Grieb, Uwe Platzbecker, et al.
British Journal of Haematology
|
August 30, 2002
CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back
Martin Bornhäuser, Uwe Platzbecker, Catrin Theuser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2007
The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors
Caroline Pabst, Holger Schirutschke, Gerhard Ehninger, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy
Tilman D Rachner, Uwe Platzbecker, Dieter Felsenberg, et al.
Leukemia
|
May 28, 2021
Current challenges and unmet medical needs in myelodysplastic syndromes
Uwe Platzbecker, Anne Sophie Kubasch, Collin Homer-Bouthiette, et al.
Frontiers in Oncology
|
March 7, 2022
Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML
Julia-Annabell Georgi, Sebastian Stasik, Martin Bornhäuser, et al.
Leukemia & Lymphoma
|
March 12, 2025
Allogeneic stem cell transplantation for MDS-clinical issues, choosing preparative regimens and outcome
Lara Bischof, Jule Ussmann, Uwe Platzbecker, et al.
Clinical Hematology International
|
November 7, 2023
Are We Ready For "Triplet" Therapy in Higher-Risk MDS?
Andrew M Brunner, Uwe Platzbecker, Amy E DeZern, et al.
Page
of 49